Abdul Muktadir, chairman and managing director of Incepta Pharmaceuticals Ltd, has been elected president of the Bangladesh Association of Pharmaceutical Industries (BAPI) for a two-year term.
The election took place during BAPI's 54th annual general meeting on March 15, according to a press release.
Md Zakir Hossain, managing director of Delta Pharma Ltd, has been elected secretary general, while Muhammad Halimuzzaman, deputy managing director and chief executive officer (CEO) of Healthcare Pharmaceuticals Ltd, will serve as treasurer for the 2025-26 and 2026-27 terms.
M Mosaddek Hossain, chairman of Unimade Unihealth Pharmaceuticals Ltd, has been elected senior vice-president, and S Kaiser Kabir, managing director and CEO of Renata PLC, will serve as vice-president.
The newly elected 20-member executive committee includes SM Shafiuzzaman, managing director of Hudson Pharmaceuticals Ltd, Md Harunur Rashid, chairman and managing director of Globe Pharmaceuticals Ltd, MA Haider Hussain, managing director of Drug International Ltd, Rabbur Reza, CEO of Senevia Pharma PLC, Hasnin Muktadir, vice-chairman of Incepta Pharmaceuticals Ltd, Md Abdur Razzaq, managing director of Nipro JMI Pharma Ltd, Simeen Rahman, managing director and group CEO of SKF Pharmaceuticals Ltd, M Mohibuz Zaman, chief operating officer of ACI Ltd, Md Nasser Shahriar Zahedi, chairman of Radiant Pharmaceuticals Ltd, KSM Mostafizur Rahman, managing director of One Pharma Ltd, Md Mizanur Rahman, executive director of Square Pharmaceuticals Ltd – Chemical Division, Fahim Sinha, director of The ACME Laboratories Ltd, Ahmed Imtiaz Hassan, director of Aristopharma Ltd, Rafidul Haq, managing director of General Pharmaceuticals Ltd – Unit-2, and Arafat Zahid Ibn Shafi, deputy managing director of Minara API Ltd.
The new committee will oversee BAPI's initiatives and work to advance the pharmaceutical sector over the next two years.
The leadership aims to enhance the industry's competitiveness in both domestic and international markets, reinforcing Bangladesh's position as a key player in the global pharmaceutical sector, the association said.
